Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Fuller

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|November 8, 2002
Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications StudyP Kempler, S Tesfaye, N Chaturvedi, et al.
Diabetologia|November 15, 2005
Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)H M Colhoun, D J Betteridge, P N Durrington, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 1999
Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications StudyF Collado-Mesa, H M Colhoun, L K Stevens, et al.
Diabetes Care|July 1, 1983
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational studyK M West, M M Ahuja, P H Bennett, et al.
Diabetologia|January 13, 2011
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan TrialsM Porta, J W Hainer, S-O Jansson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
Diabetologia|February 1, 2007
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)M Raikou, A McGuire, H M Colhoun, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 17, 2012
Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB studyB C T van Bussel, S S Soedamah-Muthu, R M A Henry, et al.
Atherosclerosis|June 24, 2003
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart diseaseS S Soedamah-Muthu, H M Colhoun, M J Thomason, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Diabetic Medicine : a Journal of the British Diabetic Association|November 8, 2002
Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications StudyP Kempler, S Tesfaye, N Chaturvedi, et al.
Diabetologia|November 15, 2005
Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)H M Colhoun, D J Betteridge, P N Durrington, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 1999
Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications StudyF Collado-Mesa, H M Colhoun, L K Stevens, et al.
Diabetes Care|July 1, 1983
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational studyK M West, M M Ahuja, P H Bennett, et al.
Diabetologia|January 13, 2011
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan TrialsM Porta, J W Hainer, S-O Jansson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
Diabetologia|February 1, 2007
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)M Raikou, A McGuire, H M Colhoun, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 17, 2012
Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB studyB C T van Bussel, S S Soedamah-Muthu, R M A Henry, et al.
Atherosclerosis|June 24, 2003
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart diseaseS S Soedamah-Muthu, H M Colhoun, M J Thomason, et al.
Pageof 17